CAVATAK

· Viralytics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CAVATAK, covering 2017-05-15 to 2019-06-17. Get the full timeline:

Most recent: Clinical Trial Update: CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON) [Phase 1]